Skip to Main content Skip to Navigation
Journal articles

Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real-world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group

Document type :
Journal articles
Complete list of metadata

https://hal.uca.fr/hal-01653723
Contributor : Dominique Chadeyron <>
Submitted on : Friday, December 1, 2017 - 6:06:12 PM
Last modification on : Tuesday, July 20, 2021 - 5:20:06 PM

Links full text

Identifiers

Citation

Sophie Michallet, Arnaud Campidelli, Helene Lequeu, Marie-Sarah Dilhuydy, Olivier Tournilhac, et al.. Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real-world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group. American Journal of Hematology, Wiley, 2017, 92 (6), pp.E105 - E107. ⟨10.1002/ajh.24715⟩. ⟨hal-01653723⟩

Share

Metrics

Record views

481